| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CDTX | Cidara Therapeutics, Inc. | Ward Shane | COO & CLO | Mar 11, 2024 | Sale | $0.67 | 20,473 | 13,713 | 198,770 | Mar 12, 2024, 09:46 PM | |
| CDTX | Cidara Therapeutics, Inc. | Ward Shane | COO & CLO | Mar 13, 2023 | Sale | $1.53 | 4,329 | 6,623 | 84,576 | Mar 13, 2023, 09:21 PM | |
| CDTX | Cidara Therapeutics, Inc. | Ward Shane | CHIEF LEGAL OFFICER | Mar 31, 2022 | Option Exercise | $0.83 | 23,122 | 19,191 | 80,905 | Apr 04, 2022, 05:12 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Ward Shane | Sr VP and Chief Legal SO | May 29, 2020 | Option Exercise | $7.63 | 107 | 816 | 1,879 | Jun 02, 2020, 12:25 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Ward Shane | Sr. VP and General Counsel | Aug 29, 2019 | Buy | $1.23 | 8,000 | 9,822 | 18,294 | Aug 30, 2019, 04:01 PM | |
| BLCM | BELLICUM PHARMACEUTICALS, INC | Ward Shane | Sr. VP and General Counsel | May 29, 2019 | Option Exercise | $2.09 | 1,065 | 2,226 | 8,935 | May 30, 2019, 04:05 PM | |
| VSAR | Versartis, Inc. | Ward Shane | SVP and General Counsel | Feb 08, 2018 | Sale | $1.80 | 4,118 | 7,412 | 201,556 | Feb 12, 2018, 05:23 PM | |
| VSAR | Versartis, Inc. | Ward Shane | SVP and General Counsel | Oct 19, 2017 | Sale | $2.55 | 776 | 1,979 | 92,574 | Oct 23, 2017, 05:01 PM | |
| VSAR | Versartis, Inc. | Ward Shane | SVP and General Counsel | Mar 14, 2017 | Sale | $19.00 | 1,265 | 24,035 | 37,126 | Mar 15, 2017, 05:31 PM | |
| VSAR | Versartis, Inc. | Ward Shane | SVP and General Counsel | Mar 15, 2017 | Sale | $19.02 | 776 | 14,760 | 36,350 | Mar 15, 2017, 05:31 PM | |
| VSAR | Versartis, Inc. | Ward Shane | SVP and General Counsel | Jan 30, 2017 | Sale | $13.85 | 1,474 | 20,418 | 38,391 | Jan 31, 2017, 08:31 PM |
Menu